A Phase 1/ Phase 2 Study of TTHX1114(NM141)

NCT04520321 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Corneal Endothelial Dystrophy
Fuchs Endothelial Corneal Dystrophy
Pseudophakic Bullous Keratopathy
Endothelial Dysfunction

Interventions

DRUG: TTHX1114(NM141)
OTHER: Vehicle (placebo)

Sponsor

Trefoil Therapeutics, Inc.